“Benefits of sequential treatment of high risk osteoporosis with teripartide and denosumab: our experience”., Actual. Osteol., vol. 12, no. 1, pp. 27–34, Jul. 2024, Accessed: Oct. 11, 2026. [Online]. Available: https://ojs.osteologia.org.ar/aaomm/index.php/osteologia/article/view/288